THOMPSON SIEGEL & WALMSLEY LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 829 filers reported holding NOVARTIS A G in Q1 2014. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.

Quarter-by-quarter ownership
THOMPSON SIEGEL & WALMSLEY LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$230.0%2290.0%0.00%
Q2 2023$23
+9.5%
2290.0%0.00%
Q1 2023$21
-75.0%
229
-75.3%
0.00%
-100.0%
Q4 2022$84
-99.9%
9290.0%0.00%0.0%
Q3 2022$71,000
-10.1%
9290.0%0.00%0.0%
Q2 2022$79,000
-35.2%
929
-33.0%
0.00%
-50.0%
Q1 2022$122,000
-28.2%
1,386
-28.8%
0.00%0.0%
Q4 2021$170,000
+1.8%
1,947
-4.6%
0.00%0.0%
Q3 2021$167,000
-24.4%
2,040
-15.9%
0.00%
-33.3%
Q2 2021$221,000
-3.5%
2,425
-9.3%
0.00%0.0%
Q1 2021$229,000
-9.5%
2,6750.0%0.00%
-25.0%
Q4 2020$253,000
+6.8%
2,675
-1.8%
0.00%
-20.0%
Q3 2020$237,000
-1.7%
2,725
-1.2%
0.01%0.0%
Q2 2020$241,000
-0.8%
2,757
-6.5%
0.01%
-16.7%
Q1 2020$243,000
-20.6%
2,950
-8.8%
0.01%
+20.0%
Q4 2019$306,000
+7.4%
3,235
-1.5%
0.01%0.0%
Q3 2019$285,000
-8.1%
3,285
-3.2%
0.01%
+25.0%
Q2 2019$310,000
-7.2%
3,395
-2.2%
0.00%
-20.0%
Q1 2019$334,000
-2.1%
3,470
-12.6%
0.01%0.0%
Q4 2018$341,000
-0.3%
3,9700.0%0.01%
+25.0%
Q3 2018$342,000
+11.4%
3,970
-2.5%
0.00%0.0%
Q2 2018$307,000
-28.1%
4,070
-23.0%
0.00%
-20.0%
Q1 2018$427,000
-15.1%
5,285
-11.7%
0.01%
-16.7%
Q4 2017$503,000
+7.2%
5,985
+9.5%
0.01%0.0%
Q3 2017$469,000
+2.9%
5,4650.0%0.01%
+20.0%
Q2 2017$456,000
-77.4%
5,465
-79.8%
0.01%
-79.2%
Q1 2017$2,014,000
+48.3%
27,115
+45.5%
0.02%
+33.3%
Q4 2016$1,358,000
-20.5%
18,640
-13.8%
0.02%
-33.3%
Q3 2016$1,708,000
+12.6%
21,635
+17.7%
0.03%
+12.5%
Q2 2016$1,517,000
-49.2%
18,385
-55.4%
0.02%0.0%
Q1 2016$2,984,000
+60.6%
41,190
+90.7%
0.02%
-27.3%
Q4 2015$1,858,000
-5.5%
21,595
+1.0%
0.03%
-10.8%
Q3 2015$1,966,000
-20.5%
21,385
-15.0%
0.04%
-15.9%
Q2 2015$2,474,000
+0.3%
25,160
+0.6%
0.04%
+2.3%
Q1 2015$2,467,000
-1.4%
25,015
-7.4%
0.04%
-10.4%
Q4 2014$2,503,000
-17.4%
27,016
-16.0%
0.05%
-20.0%
Q3 2014$3,029,000
-75.1%
32,181
-76.0%
0.06%
-74.6%
Q2 2014$12,146,000
-4.4%
134,162
-10.2%
0.24%
-17.5%
Q1 2014$12,701,000
+5.8%
149,387
-0.0%
0.29%
+1.8%
Q4 2013$12,008,000
+4.4%
149,390
-0.3%
0.28%
+12.4%
Q3 2013$11,499,000
+8.3%
149,900
-0.1%
0.25%
+8.7%
Q2 2013$10,615,000150,1250.23%
Other shareholders
NOVARTIS A G shareholders Q1 2014
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders